CVS Health Valuation Overview

CVS -- USA Stock  

USD 72.88  1.21  1.63%

CVS Health shows prevailing Real Value of $82.0988 per share. The current price of the firm is $72.88. At this time the firm appears to be under valued. Macroaxis approximates value of CVS Health from analyzing the firm fundamentals such as Return On Equity of 8.71% and Profit Margin of 1.65% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point future time assets prices and their ongoing real values will blend.

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
CVS Health Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

CVS Health Market Cap

CVS Health Corporation is rated third in market capitalization category among related companies. Market capitalization of Health Care Plans industry is currently estimated at about 537.98 Billion. CVS Health retains roughly 99.02 Billion in market capitalization claiming about 18% of equities under Health Care Plans industry.
Capitalization  Revenue  Total debt  Valuation  Workforce
Horizon     30 Days    Login   to change
CVS Health Corporation is rated below average in price to earning category among related companies. It is rated below average in beta category among related companies totaling about  0.04  of Beta per Price to Earning. The ratio of Price to Earning to Beta for CVS Health Corporation is roughly  25.18 

Current Market Valuation

CVS Health Valuation Boundaries

Under Valued
December 10, 2018
Market Value
Real Value
Target Odds
CVS Health is not too risky asset. Calculation of real value of CVS Health is based on 2 months time horizon. Increasing CVS Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

CVS Health Enterprise Value Fundamentals

Quick Ratio1.92
Earnings Quarterly Growth8.20%
Revenue Growth2.40%
Payout Ratio66.01%
Enterprise Value To Ebitda8.06
Earnings Growth7.90%
Enterprise Value To Revenue0.54
Check also Trending Equities. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.